CDK18 and neoplasm: Initial indications of CDK18 potential involvement in tumor progression emerged from studies showing that silencing CDK18 inhibited the growth of cutaneous T-cell lymphoma cells, suggesting that CDK18 may play a role in promoting their growth [123].